Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells
Autori principali: | Dan Nakano, Takumi Kawaguchi, Tsubasa Tsutsumi, Masako Hayakawa, Sachiyo Yoshio, Hironori Koga, Takuji Torimura |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Wiley
2022-04-01
|
Serie: | JGH Open |
Soggetti: | |
Accesso online: | https://doi.org/10.1002/jgh3.12730 |
Documenti analoghi
Documenti analoghi
-
Gene cloning and expression analysis of Gro/KC by primary hepatocytes
di: GH. Hassanshahi, et al.
Pubblicazione: (2007-01-01) -
Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells
di: Elodie Jouan, et al.
Pubblicazione: (2016-12-01) -
Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
di: Toru Nakamura, et al.
Pubblicazione: (2024-10-01) -
Chemokines, chemokine receptors and disease : current topics in membranes /
di: Schwiebert, Lisa M.
Pubblicazione: (2005) -
A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis
di: Yoshihiro Shidoji, et al.
Pubblicazione: (2021-12-01)